IMF Patient & Family Webinar - Back to Basics: From Testing to Tailored Therapy

IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie will moderate presentations with the following myeloma experts:

Paul Richardson, MD (Dana-Farber Cancer Institute, Boston, MA)
Saad Usmani, MD (Memorial Sloan Kettering Cancer Center, New York, NY)
Mary Steinbach, DNP, APRN (Hunstman Cancer Institute, Salt Lake City, UT)

0:05:42 - Recommended Testing and Monitoring: 2022 Algorithms - Brian Durie, MD.
A discussion which will cover required testing for diagnosis and monitoring, new testing approaches, as well as Mass Spectrometry and molecular analyses. 2022/2023 Myeloma care guidelines throughout the disease course will also be presented, with an open discussion of key options.

0:46:40 - Frontline Options - Paul Richardson, MD
Frontline therapy will be discussed in the context of the role of autologous stem cell transplant (ASCT) and the use of quadruplets (four-drug combinations) vs triplets (three-drug combinations). The results of the DETERMINATION Trial (Triplet VRd +/- upfront ASCT) will be the starting point for discussions and questions.

1:36:02 - Managing Myeloma Care -Mary Steinbach, DNP, APRN
Questions about the overall approach to supportive care will be answered. It is particularly important to review and open discussions about special side effects and/or toxicities brought about by new and emerging therapies.

2:03:16 - Relapse Options: FDA Approved/Clinical Trials - Saad Usmani, MD
How to manage relapsing disease from the perspective of both currently approved and available therapies, as well as clinical trial options. He will particularly focus on the potential role of bispecific antibodies in new and emerging treatment paradigms—an area with many questions that need to be addressed.

Download Slides here: https://www.myeloma.org/videos/imf-pa...

_______________
Improving Lives | Finding the Cure

Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.

Subscribe to our channel:    / imfmyeloma  

Visit our website at: https://www.myeloma.org

Find us online:
Facebook: @myeloma |   / myeloma  
Twitter: @IMFMyeloma |   / imfmyeloma  
Instagram: @imfmyeloma |   / imfmyeloma  
LinkedIn:   / international-myeloma-foundation  

Support the IMF! http://bit.ly/WskQHC
Category
Nonprofits & Activism
License
Standard YouTube License

In most cases, captions are autogenerated by YouTube.